Private equity’s new physician-acquisition strategy

Private equity firms have solidified their place in healthcare over the last decade. 2012 saw just 75 PE transactions in healthcare –– in 2021, that number reached 484. 

Advertisement

Although PE transactions decreased in 2023 compared with previous years, an Aug. 8 blog post by Troutman Pepper, a PE firm, suggests that many firms are “holding onto large amounts of uninvested capital,” and that healthcare is drawing investors. 

In the post, Troutman  highlights a new acquisition strategy that emphasizes equity “rollover” rather than all-cash purchases. In this strategy, the buyer forms or uses an existing management services organization sponsored by the PE firm to manage the non-clinical aspects of the acquired practice. The selling physicians then receive shares in the MSO, as well as cash at closing. 

According to Troutman, this arrangement serves to reduce the cash required upfront by the PE firm. It also gives the selling physicians opportunities to share in the growth of the MSO. At the same time, PE firms can meet regulatory requirements that prohibit non-physician ownership of medical practices and other compliance regulations.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Private Equity

Advertisement

Comments are closed.